Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts
M2 - Fri Mar 14, 10:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4bhvn/diabetes_herbal) has announced the addition of the Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts report to their offering. Diabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of Diabetes, the most serious problem is the side effect, which occurs due to the accumulation of glucose. This excess glucose is converted into various compounds and also into free radicals, which damage the vital organs and organelles. Diabetes was seriously underrated as a threat to global public health until very recently. Today, Diabetes now ranks as one of the greatest public health challenges in the history of mankind. There were 382 million people with Diabetes, or 8.3% of the global population, in 2013. By 2035, this number will be 10.1%, equal almost 600 million people worldwide. Diabetes has a very large economic impact. For example, in the US the cost of diagnosed Diabetes in 2012 is estimated at US$245 billion, including $176 billion in direct medical costs. In 2013, the average Diabetes related expenditures per person in the US was USD9,800. Globally, per capita Diabetes related expenditures in 2013 was USD1,436. Further, the global market for Diabetes medications is estimated at approximately USD45 billion in 2013 and is growing 10.5% annually overall, with insulin sales increasing at a 14.2% CAGR. The currently available antidiabetic drugs manage the blood glucose levels under normal range by supplementing insulin, improving insulin sensitivity, increasing insulin secretion from the pancreas, decreasing glucose absorption from the intestinal tract and/or glucose uptake by tissue cells. Today, the management of Diabetes without any side effect is still a challenge to the medical fraternity. However, a wide array of plant-derived active principles has demonstrated antidiabetic activity. These natural medicines modulate blood sugar levels through a variety of mechanisms. In some cases their effects are similar to conventional medicines. This report looks at the use of medicinal plants, rather than pharmaceutical drugs, to both prevent and treat Diabetes. Specifically, it looks in detail at one of these plants: Cinnamon. Cinnamon is widely used and available and the market for it is well developed. The modern literature indicates that the potential antidiabetic properties of Cinnamon have been studied for over 20 years. Numerous trials have been conducted in humans to determine the metabolic effects of Cinnamon. This report provides: - A detailed look at the Diabetes market including its incidence by country now and during the next 20 years, economic impacts and costs by type, especially medications. - Analysis of medicinal plants to manage Diabetes including experimental studies on the hypoglycaemic activity and bioactive components of 66 plants. - The potential of Cinnamon for the management of Diabetes including its biological effects, molecular mechanisms of action and clinical studies. - Analysis of the global market for Cinnamon including production, imports, exports and traders. Additionally, profiles of 45 leading, public and private companies involved in the Cinnamon industry as producers, distributors, and retailers are given. The report also includes 30 tables and 50 figures. Key Topics Covered: CONTENTS EXECUTIVE SUMMARY INTRODUCTION Background Methodology and Sources Statistical Notes DIABETES MARKET OVERVIEW - Pandemic - Orthodox Approach - Lifestyle Changes - Diet - Nonorthodox Approach: Medicinal Plants - Global Economic Impact Of Diabetes - World Population Of 20-79 Year Olds: 2013-2035 - Diabetes Incidence By Country - Diabetes Prevalence By Country: 2013-2035 - Diabetes-Related Expenditure Per Person By Country: 2013-2035 - Economic Costs Of Diabetes In The US - US Diabetes Costs By Type - Diabetes Medications Company Market Shares - Insulin Is The Final Solution - Insulin Market Growth Drivers - Insulin Market Value Drivers - Insulin Market Growth: 2008-2013 - Insulin Market Growth By Region - Insulin Market Segments (Fast Acting, Premix, Long Acting) - GLP-1 MEDICINAL PLANTS AND DIABETES - Conventional Treatment - Conventional Antidiabetic Drugs - Medicinal Plants: A Safe Tool To Manage DM - Mechanism Of Action In Commonly Used Medicinal Plants - Pharmacologically Screened Insulinomimetic Or Insulin Secretagogues Plant Material And Phytoconstituents - Experimental Studies On Hypoglycaemic Activity And Bioactive Components Of 66 Plants - Acacia arabica - Aegle marmelos - Agrimony eupatoria - Allium sativum - Aloe vera - Annona muricata - Annona squamosa - Asparagus racemosus - Bauhinia variegata - Berberine - Biophytum sensitivum - Boerhaavia diffusa - Bougainvillea spectabilis - Brassica nigra - Caesalpinia bonducella - Caffeine - Camellia sinensis - Capsicum frutescens - Catharanthus roseus - Cinnamon zeylaniucm - Citrullus colocynthis - Coccinia indica - Cornus officinalis - Elephantopus scaber - Enicostemma littorale - Ephedra distachya - Eriobotrya japonica - Euccalyptus globulus - Eugenia jambolana - Ficus bengalensis - Fermented Unsalted Soybeans - Genistein - Ginkgo biloba - Radix glycyrrhizae - Gymnema sylvestre - Helicteres isora - Hibiscus rosa sinensis - Hordeum vulgare - Lepechinia caulescens - Medicago sativa - Momordica charantia - Mucuna pruriens - Nigella sativa oil - Panax ginseng - Pandanus odorus - Parinari excelsa - Prunella vulgaris - Psidium guajava - Pterocarpus marsupium - Radix rehmanniae - Rehmania glutinosa - Ricinus communis - Syzygium cumini - Salvia lavandifolia - Sarcopoterium spinosum - Selaginella tamariscina - Semen coicis - Smallanthus sonchifolius - Stevia rebaudiana - Swertia chirayita - Swertia punicea - Tabernanthe iboga - Teucrium polium - Tinospora crispa - Tribuluks terrestris - Trigonella foenum-graecum - Zizyphus spina-christi - Conclusions - Medicinal Plant Market - Production - Exports - Imports - Trade Balance CINNAMON AND DIABETES - Definition - Genus Cinnamomum - Species - Flavor, Aroma And Taste - History - Early History - Modern History - Agronomy Research And Development Efforts - Cultivation - Grading - Processing - Uses - Adverse Effects - Clinical Potential Of Cinnamon For The Management Of Diabetes - Biological Effects Of Cinnamon - Cinnamon Has Been Studied For Over 20 Years - Molecular Mechanisms Of Action Of Cinnamon - Clinical Studies With Cinnamon - Conclusions CINNAMON MARKET OVERVIEW - Cinnamon Vs. Medicinal Plant Production - Production - Cinnamon Market: 1992-2013 - Cinnamon Market Outlook: 2014-2019 - Cinnamon Exports By Country - Cinnamon Trade Balance By Country - Cinnamon Export And Import Companies COMPANY PROFILES A.A. Sayia & Company, Inc A. Baur & Co (Pvt.) Ltd. ACH Food Companies, Inc. Adam Group Adams Extract & Spice, LLC Ajinomoto Co., Inc. Bart Ingredients Company Ltd Bio Foods Pvt Ltd Bolner's Fiesta Products Ceylon Spice Company C.F. Sauer Company EOAS International Everson Spice Company First Spice Mixing Company Frontier Natural Products Co-op Inc. Goya Foods, Inc. HDDES Group Hong Son Cassia & Star Aniseed Processing Co., Ltd. Horn Company Huong Que Company Indus Organics Integrity Nutraceuticals International Founded Intercom Limited Ishana Spice Exports L B Spices Trading (Private) Limited La Flor Spices La India Packing Company McCormick & Company, Incorporated Monteray Bay Spice Company Mountain Rose Herbs Nature's Agro Products Lanka Company Novo Nordisk A/S Olam International Limited Orient Vietnam Company Limited PT Cassia Co-Op PT Dwiwarna Inti Sejahtera Rathna Producers Cinnamon Exports (Pvt) Ltd. Saboor Chatoor (Private) Limited SC Seasoning Co., Inc. SDS Spices (PVT) Ltd. Spice House USA The Empire Associates Tripper Vanns Spices Whole Foods Market, Inc. Wixon Inc. APPENDIX 1: DIABETES OVERVIEW - Classification - Insulin - Untreated Diabetes - Treated Diabetes - Poor Diagnosis Rates - Type 2 Medications - History - Type 1 Diabetes - Cause - Genetics - Environmental - Diet - Chemicals And Drugs - Pathophysiology - Diagnosis - Tight Glycaemic Control - Autoantibodies - Prevention - Immunosuppressive Drugs - Management - Pancreas Transplantation - Islet Cell Transplantation - Stem Cell Educator Therapy - Depression - Eating Disorders - Complications - Time Of Diagnosis - GAD65 Vaccine - T Helper Cell Shift - Labile Diabetes - Type 2 Diabetes - Signs and Symptoms - Complications - Cause - Lifestyle - Genetics - Medical Conditions - Pathophysiology - Diagnosis - Prevention - Management - Lifestyle - Medications - Surgery - Metabolic Syndrome - History - Definitions And Diagnosis - IDF - WHO - EGIR - NCEP - American Heart Association - Other - Etiology - Pathophysiology - Stress - Overweight And Obesity - Sedentary Lifestyle - Aging - Type 2 Risk - Coronary Heart Disease - Lipodystrophy - Psychiatric Illnesses - Rheumatic Diseases - Signs and Symptoms - Prevention - Therapy - Controversy - Diabetes And Food Prices APPENDIX 2: INSULIN OVERVIEW - Gene - Alleles - Regulation - Protein Structure - Synthesis - Release - Oscillations - Blood Content - Signal Transduction - Effect On Glucose Uptake and Metabolism - Degradation - Hypoglycemia - Diseases And Syndromes - Medication - Discovery - Extraction And Purification - Synthesis - Nobel Prizes - Glucagon-Like Peptide-1 - Physiological Functions - Leptin - Physiology - Function - Adiposity Signal - Interaction With Amylin - Metreleptin TABLES 1.) Global Diabetes Market Summary: 2014-2019 (Diabetes Cases (Million), Diabetes Related Expenditures Per Person (USD), Total Diabetes Related Expenditures (USD Billion), Total Diabetes Medications Demand (USD Billion), Medicinal Plants Production (USD Billion), Cinnamon Production (USD Million) 2.) Population Of 20-79 Year Olds Ranked For The World And 218 Countries Plus Growth Rates: 2013-2035 3.) Diabetes Cases (1000s) Among 20-79 Year Olds Ranked For The World And 218 Countries Plus Growth Rates: 2013-2035 4.) Diabetes National Prevalence (%) Ranked For The World And 218 Countries: 2013-2035 5.) Diabetes-Related Expenditures Per Person With Diabetes For The World And 218 Countries (USD): 2013 6.) US Health Care Expenditures By Diabetes Status And Type Of Service (USD Million): 2012 7.) US Health Care Expenditures Attributed To Diabetes By Age Group And Type Of Service (USD Million): 2012 8.) US Per Capita Health Care Expenditures Attributed To Diabetes By Age Group And Type Of Service (USD Million): 2012 9.) US Health Care Expenditures Attributed To Diabetes By Medical Condition And Type Of Service (USD Million): 2012 10.) US Annual Per Capita Health Care Expenditures By Diabetes Status (Actual Dollars): 2012 11.) Existing Synthetic Drugs For Type 2 DM In Market And Their Molecular Targets, Site Of Action And Adverse Reactions 12.) Commonly Used Conventional And Natural Medicines For Diabetes 13.) List Of Plants Having Antidiabetic Activity 14.) List of Plants Having Insulin Mimetic Or Insulin Secreatory Activity 15.) List Of Plants Phytoconstituents Having Insulin Secretagogues Or Insulin Mimetic Activity 16.) Global Medicinal Plant Exports By Country And Growth Rate (USD Thousands): 2008-2012 17.) Global Medicinal Plant Imports By Country And Growth Rate (USD Thousands): 2008-2012 18.) Global Medicinal Plant Trade Balance By Country And Growth Rate (USD Thousands): 2008-2012 19.) Summary Of Human Studies Where Patients With Type 2 Diabetes, Metabolic Syndrome, Impaired Fasting Glucose And Associated Diseases Were Treated With Cinnamon 20.) Global Medicinal Plant Vs. Cinnamon Production (USD Million): 2014-2019 21.) Global Cinnamon Production By Country (Metric Tons): 1982-2012 22.) Global Cinnamon Market (USD Million, Metric Tons, Average Selling Price): 1992-2013 23.) Global Cinnamon Market (USD Million, Metric Tons, Average Selling Price): 2014-2019 24.) Global Exports Of Cinnamon For World And 121 Countries (USD Thousand): 2008-2012 25.) Global Imports Of Cinnamon For World And 198 Countries (USD Thousand): 2008-2012 26.) Global Trade Balance Of Cinnamon For World And 202 Countries (USD Thousand): 2008-2012 27.) 481 Cinnamon Export Companies By Country (Name, Product/Service Categories Traded, Employees, Country, Website): 2014 28.) 201 Cinnamon Import Companies By Country (Name, Product/Service Categories Traded, Employees, Country, Website): 2014 29.) Comparison Of Type 1 And Type 2 Diabetes 30.) Commonly Prescribed Products For The Treatment Of Type 2 Diabetes FIGURES 1.) Global Diabetes Medications Market By Treatment Class (GLP-1, Insulin, OAD): 2003-2013 2.) Global Diabetes Medications Market Shares By Company (%): 2003-2013 3.) Progression Of Type 2 Diabetes And Treatment Intensification 4.) Distribution Of Patients And Value Across Treatment Classes 5.) Global Insulin Market Growth By Component: 2008-2013 6.) Global Insulin Market: Device Penetration Vs. Modern Insulin Penetration 7.) Global Modern Insulin Volume Company Market Shares 8.) Insulin Market Size And Growth By Region, Volume Composition, Volume Market Shares By Company: 2012-2013 9.) Regional (North America, Europe, China, Japan, Korea) Insulin Market Volume Growth Rates: 2003-2013 10.) Regional (North America, Europe, China, Japan, Korea) Insulin Volume Market Split: 2003-2013 11.) Action Profiles Of Insulins By Type 12.) Global Insulin Market Volume And Growth By Segment: 2008-2013 13.) Global GLP-1 Market Value And Market Share: 2008-2013 14.) GLP-1 Market By Region (%): 2013 15.) US GLP-1 Market-Victoza Vs. Other GLP-1(Value, TRx Scripts, % of Diabetes Care): 2010-2013 16.) Germany, UK And France Markets for GLP-1: Victoza Vs. Other GLP-1 Products (Value, % of Diabetes Care): 2009-2013 17.) Effects Of Phytochemicals in Insulin Secretion And Pancreatic--cell Apoptosis 18.) Cinnamomum verum 19.) Cinnamon Trees 20.) Cinnamon Products 21.) Flow Diagram Of Cinnamon Processing 22.) Mechanisms Of Action Of Cinnamon In Relevant Metabolic Pathways 23.) Novo Nordisk Diabetes Care Revenues By Segment (DKK Billion): 2013 24.) Novo Nordisk MAT Diabetes Care Sales Growth By Segment (%): 2008-2013 25.) Novo Nordisk Global And Regional Insulin Market Shares: 2013 26.) Novo Nordisk Revenue And Growth By Product and Region: 2009-2013 27.) Novo Nordisk Volume Market Share Across Insulin Classes 28.) Novo Nordisk Brand Names, Product Types, Sales, Market Shares, Patent Expirations: 2013 29.) Novo Nordisk's Modern Insulins Volume Market Share By Segment 30.) Novo Nordisk Product Growth And Market Shares By Segment: 2008-2013 31.) Novo Nordisk Modern Insulin US Market Share By Market Segment: 2008-2013 32.) US Insulin Supplier Volume Market Shares (%): 2013 33.) European Insulin Supplier Volume Market Shares (%): 2013 34.) Chinese Insulin Supplier Volume Market Shares (%): 2013 35.) Japanese Insulin Supplier Volume Market Shares (%): 2013 36.) Novo Nordisk Current And Future Product Portfolio 37.) Novo Nordisk R&D Pipeline: Diabetes And Obesity 38.) Insulin Secretion Profile 39.) Insulin Enables Glucose To Become Energy 40.) Insulin Level Vs. Time Of Day 41.) Diabetes Diagnosis And The Rule Of Halves 42.) Glycaemic Control In Selected Countries (%) 43.) Diabetes Prevalence And Diagnosis Rates By Region: 2013 44.) Main Symptoms of Diabetes 45.) Risk Reduction By Class From Lowering HbA1c By 1%-Point 46.) Insulin Synthesis Process 47.) Insulin Oscillations 48.) Idealized Diagram Of Blood Sugar Fluctuation 49.) Effect Of Insulin On Glucose Uptake And Metabolism 50.) The Structure Of Insulin Companies Mentioned: - A. Baur & Co (Pvt.) Ltd. - A.A. Sayia & Company, Inc - ACH Food Companies, Inc. - Adam Group - Adams Extract & Spice, LLC - Ajinomoto Co., Inc. - Bart Ingredients Company Ltd - Bio Foods Pvt Ltd - Bolner's Fiesta Products - C.F. Sauer Company - Ceylon Spice Company - EOAS International - Everson Spice Company - First Spice Mixing Company - Frontier Natural Products Co-op Inc. - Goya Foods, Inc. - HDDES Group - Hong Son Cassia & Star Aniseed Processing Co., Ltd. - Horn Company - Huong Que Company - Indus Organics - Integrity Nutraceuticals International Founded - Intercom Limited - Ishana Spice Exports - L B Spices Trading (Private) Limited - La Flor Spices - La India Packing Company - McCormick & Company, Incorporated - Monteray Bay Spice Company - Mountain Rose Herbs - Nature's Agro Products Lanka Company - Novo Nordisk A/S - Olam International Limited - Orient Vietnam Company Limited - PT Cassia Co-Op - PT Dwiwarna Inti Sejahtera - Rathna Producers Cinnamon Exports (Pvt) Ltd. - SC Seasoning Co., Inc. - SDS Spices (PVT) Ltd. - Saboor Chatoor (Private) Limited - Spice House USA - The Empire Associates - Tripper - Vanns Spices - Whole Foods Market, Inc. - Wixon Inc. For more information visit http://www.researchandmarkets.com/research/b4...tes_herbal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HealthEconomics.Com Produces Webinar on Technology Use in Global Clinical Trials in Emerging Regions
PRWeb - Mon Jan 13, 4:03AM CST
Two leading pharmaceutical clinical trial experts presented a webinar on January 9, 2014 entitled "Running Successful Trials in Emerging Regions: Using Technology to Maximize Success." The webinar, attended by clinical trial researchers worldwide, was sponsored by ERT and Pharm-Olam International, and produced and moderated by HealthEconomics.Com. ERT is a leading global solution provider for high-quality patient safety and efficacy endpoint data collection. Pharm-Olam International is a global full-service Contract Research Organization providing clinical services to pharmaceutical, biotechnology and medical device organizations, while HealthEconomics.Com is a website portal and Connected Community serving as the global authority in healthcare value, health outcomes, and pharmaceutical market access.
Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013
PR Newswire - Fri Sep 06, 7:00AM CDT
Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced the 2nd Annual Sickle Cell Disease Therapeutics Conference will take place on September 19th, 2013 at the Four Seasons Hotel in New York City (Cosmopolitan Suite). The conference is intended to serve as a forum to raise awareness for sickle cell disease and will include presentations from leading companies in sickle cell disease and discussions with experts regarding the latest advancements and trends in treatment. Conference sponsors include The Pierre Fabre Foundation, Canaccord Genuity, Piper Jaffray, Sheppard Mullin Richter & Hampton, LLP, Pharm-Olam International and Theradex Systems, Inc.
The Sustainability Transition: Impacts to Agriculture
M2 - Tue Aug 06, 4:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3xgx8k/the) has announced the addition of the "The Sustainability Transition: Impacts to Agriculture" report to their offering. Sustainability is a term used frequently in discussions about the future of agriculture. All stakeholders agree that it is critically important, but to date, there is little agreement as to its definition or whether it is a goal or a set of practices. Much of the discussion about agricultural sustainability has been about what should be done to ensure agriculture is sustainable in the long term. The purpose of this report is to provide an objective analysis of what is actually happening and to explain what the major drivers of sustainability are and how they are likely to affect the future. The report discusses the commercial implications for agricultural organizations, from food production through retailing. It focuses on five major drivers identified as those propelling the agricultural sustainability movement, as they vary by geography and food type. It reviews what is most important for firms operating at different points within the food value chain and highlights the most significant sustainability issues. In addition, the study describes the drivers, opportunities and risks that can help organizations adapt to changes related to sustainability issues. It is meant to assist organizations in adjusting their business strategies to the growing challenge, for all of agriculture, to intensify production to meet future demand while preserving/enhancing the earth's fertility and productive capacity. Key Market Issues - Growing demand for food worldwide. - Resource constraints, especially on water and land. - NGO pressures on government to regulate agricultural practices and externalities. - Consumer concerns about health and food safety. - Distribution chain requirements to modify agricultural practices to seek greater profit or favor with consumers. Key Topics Covered The Sustainability Transition: Impacts to Agriculture report consists of of four parts: Part 1, Background Part 2, A Current View of Sustainable Agriculture Part 3, Adoption & Adaptation in Agribusiness Part 4, Sustainable Agriculture in 2030 Examples of Companies Mentioned - Aldi - BASF - Bayer CropScience - Brasil Foods - Carrefour - China Yuran Food Group - Chiquita - Coca-Cola - Danish Crown - Delhaize - Dole - Dow AgroScience - DuPont - General Mills - Heineken - ICA - JBS - Kraft - Limagrain - McDonalds - Metro - Migros - Monsanto - Nestle - NuFarm - Olam International - People's Food - Pepsico - Schwarz Group - Shoprite - Smithfield Foods - Tesco - The Nobel Group - Tyson - Unilever - Walmart For more information, including full list of companies mentioned, please visit http://www.researchandmarkets.com/research/3xgx8k/the About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The Sustainability Transition: Sustainable Agriculture Background
M2 - Wed Jul 31, 3:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cd33zq/the) has announced the addition of the "The Sustainability Transition: Sustainable Agriculture Background" report to their offering. Sustainability has become a very popular term in the corporate and political world. For some industries, sustainability is largely a public relations issue, but for agriculture it's becoming a strategic issue and one that is increasingly going to affect financial performance. 'The Sustainability Transition: Sustainable Agriculture Background' provides readers with a strategic overview of the sustainability movement tracing its origins from the environmental movement to its current role as an umbrella for a host of ecological, health and social causes and initiatives. It compares and contrasts differing definitions and understandings of what sustainability encompasses and the issues that are most important to its proponents. Key Topics Covered - Introduction - Defining Sustainability & Sustainable Agriculture - A Goal, a Set of Practices or a Movement - Comparison of Various Farming Systems - History of the Sustainability Movement - The Rise of Monoculture Farming - The Green Revolution - Earth Day - Environmentalism - The Earth Summit (Rio De Janeiro) - 2008 Food Price Spikes - Review of Major Sustainability Issues - Food Security Yield - Climate Change - Biotechnology - Organic Agriculture - Consumer Attitudes & Understanding of Sustainability Examples of Companies Mentioned - Ahold - Aldi - BASF - Bayer CropScience - Brasil Foods - Bunge - Cargill - Carrefour - Chiquita - Coca-Cola - Dole - Dow AgroScience - DuPont - General Mills - Grupo P?o de A??car - Heineken - ICA - JBS - Kraft - Makhteshim Agan - McDonalds - Monsanto - Nestle - NuFarm - Olam International - Pantaloon - People's Food - Pepsico - Schwarz Group - Shineway - Shoprite - Smithfield Foods - Syngenta - Tesco - Unilever - VION - Walmart For more information visit http://www.researchandmarkets.com/research/cd33zq/the About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The Sustainability Transition: Adoption & Adaptation In Agri-Business
M2 - Mon Jul 22, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5f5mbw/the) has announced the addition of the "The Sustainability Transition: Adoption & Adaptation In Agri-Business" report to their offering. Sustainability has become a very popular term in the corporate and political world. For some industries, sustainability is largely a public relations issue, but for agriculture it's becoming a strategic issue and one that is increasingly going to affect financial performance. 'The Sustainability Transition: Adoption & Adaptation in Agribusiness' provides an analysis of the adoption and adaptation along the food value chain, highlighting where the sustainability movement has had the greatest impact. It also includes a review of the specific sustainability strategies and actions that major players in the agricultural industry are already implementing. Key Topics Covered Introduction - Food Retailers - Industry Description & Trends - Key Sustainability Issues - Retail Food Industry Sustainability Policies & Initiatives - Review Of Segment Leaders Sustainability Policies/Activities - Summary Food Manufacturers - Industry Description & Trends - Packaged Food Industry Sustainability Policies & Initiatives - Review of Segment Leaders' Sustainability Policies/Activities - Summary Agro Processors - Industry Description & Trends - Key Sustainability Issues - Agro-Processing Industry Sustainability Policies & Initiatives - Review of Segment Leaders' Sustainability Policies/Activities - Summary - Meat Processors - Industry Description & Trends - Key Sustainability Issues - Meat Packing Industry Sustainability Policies & Initiatives - Review of Segment Leaders' Sustainability Policies/Activities - Summary Plant Science Industry - Industry Description & Trends - Key Sustainability Issues - Plant Science Industry Sustainability Policies & Initiatives - Review Of Segment Leaders' Sustainability Policies/Activities - Summary Company Sustainability Strategies Examples Companies Mentioned - Ahold - Aldi - BASF - Bayer CropScience - Brasil Foods - Carrefour - China Yuran Food Group - Chiquita - Danish Crown - Dow AgroScience - DuPont - General Mills - Grupo P?o de A??car - Heineken - ICA - JBS - Kraft - Lianhua - Louis Dreyfus Commodities - Makhteshim Agan - McDonalds - Metro - Migros - Monsanto - Nestle - NuFarm - Olam International - Pantaloon - Shineway - Smithfield Foods - Tate & Lyle - Tesco - Tyson - Unilever - Walmart For more information visit http://www.researchandmarkets.com/research/5f5mbw/the About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Pharm-Olam Bolsters Project Management Leadership
PRWeb - Mon Jun 24, 9:12AM CDT
Pharm-Olam International Ltd. a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced the appointment of Colleen McAuliffe, PhD. PMP to the position of Vice President, Global Project Management. In this new role McAuliffe will be responsible for implementing a global project management strategy focusing on operational integration, knowledge management, technical alignment, capacity planning, and expedited study enrollment.
Pharm-Olam Performs Clinical Trial Services in Kazakhstan
PRWeb - Thu May 30, 1:30PM CDT
Pharm-Olam International Ltd., a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced its successful expansion of clinical trial services into Kazakhstan.
Global Food and Beverage Survey 2013-2014 - The Projected Average Global Annual Procurement Budget for Buyer Respondents Is US$435 Million In 2013
M2 - Thu Apr 25, 10:18AM CDT
Research and Markets has announced the addition of Canadean Ltd's new report "Global Food and Beverage Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Food and Beverage Industry" to their offering. What is the current market landscape and what is changing? According to survey results, 68% and 48% of global food and beverage manufacturer respondents are 'more optimistic' about the revenue growth for their company in 2013 respectively. Key Highlights An analysis of revenue growth expectations by senior level respondents reveals that 52% are 'more optimistic' about their company's revenue growth in 2013. Survey results show that, 48% and 35% of supplier respondents respectively project at least some increase in capital expenditure on 'new product development' and 'sustainable or green initiatives' in 2013. Across the global food and beverage manufacturers' industry, the top three expected key changes in business structure are addition of 'new products and services', '
Global Food and Beverage Survey 2013 - Economic Outlook in BRIC - Respondents from Small and Large Companies Indicate High Growth in Brazil
M2 - Fri Apr 12, 11:50AM CDT
Research and Markets has announced the addition of Canadean Ltd's new report "Global Food and Beverage Survey 2013 - Economic Outlook in BRIC" to their offering. Global Food and Beverage Industry Survey 2013: Economic Outlook in BRIC is a new report by Canadean that provides the reader with an extensive and authoritative analysis of the economic outlook in BRIC for 2013. This report identifies respondents' current business scenario with BRIC nations and demonstrates respondents' intentions of changes in the economic outlook in 2013. In addition, the global food and beverage industry survey report provides a comprehensive account of the opinions conveyed by executives to help the reader to judge which of the BRIC nations could really be the drivers of the global economy in 2013. Key Highlights In total, 59% and 53% of supplier respondents consider China' and India' as the most significant BRIC markets respectively. Canadean's industry survey reveals that manufacturer respondents gave comparatively more pr
InSite Vision Completes Phase 3 Clinical Study of BromSite for the Reduction of Pain and Inflammation After Cataract Surgery
Business Wire - Thu Jan 10, 7:30AM CST
InSite Vision Incorporated (OTCBB: INSV) today announced that the last patient has completed dosing and evaluation in the Phase 3 clinical trial of BromSite(TM) (ISV-303) for the reduction of pain and inflammation after cataract surgery. BromSite combines a low dose (0.075%) of the non-steroidal anti-inflammatory drug (NSAID) bromfenac with InSite Vision's DuraSite(R) drug delivery technology.